AU2001239731A1 - Chimeric neuropeptide y receptors - Google Patents

Chimeric neuropeptide y receptors

Info

Publication number
AU2001239731A1
AU2001239731A1 AU2001239731A AU3973101A AU2001239731A1 AU 2001239731 A1 AU2001239731 A1 AU 2001239731A1 AU 2001239731 A AU2001239731 A AU 2001239731A AU 3973101 A AU3973101 A AU 3973101A AU 2001239731 A1 AU2001239731 A1 AU 2001239731A1
Authority
AU
Australia
Prior art keywords
neuropeptide
chimeric
receptors
chimeric neuropeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001239731A
Inventor
Michele Bennett
Robbin Brodbeck
James Krause
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurogen Corp
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Publication of AU2001239731A1 publication Critical patent/AU2001239731A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001239731A 2000-01-28 2001-01-29 Chimeric neuropeptide y receptors Abandoned AU2001239731A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17865200P 2000-01-28 2000-01-28
US60178652 2000-01-28
PCT/US2001/002804 WO2001055103A2 (en) 2000-01-28 2001-01-29 Chimeric neuropeptide y receptors

Publications (1)

Publication Number Publication Date
AU2001239731A1 true AU2001239731A1 (en) 2001-08-07

Family

ID=22653365

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001239731A Abandoned AU2001239731A1 (en) 2000-01-28 2001-01-29 Chimeric neuropeptide y receptors

Country Status (6)

Country Link
US (3) US20010031474A1 (en)
EP (1) EP1263768A4 (en)
JP (1) JP2004500820A (en)
AU (1) AU2001239731A1 (en)
CA (1) CA2394332A1 (en)
WO (1) WO2001055103A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001023389A2 (en) 1999-09-30 2001-04-05 Neurogen Corporation Certain alkylene diamine-substituted heterocycles
CZ20021067A3 (en) * 1999-09-30 2002-11-13 Neurogen Corporation Certain alkylenediamine substituted pyrazolo[1,5-a]- 1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
WO2001055103A2 (en) * 2000-01-28 2001-08-02 Neurogen Corporation Chimeric neuropeptide y receptors
ES2249384T3 (en) 2000-12-12 2006-04-01 Neurogen Corporation ESPIRO (ISOBENZOFURAN-1,4'-PIPERADIN) -3-ONAS AND 3H-ESPIROBENZOFURAN-1,4-PIPERIDINAS.
CA2403307A1 (en) 2001-10-23 2003-04-23 Neurogen Corporation Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
US20060160834A1 (en) * 2003-06-06 2006-07-20 Fong Tung M Combination therapy for the treatment of hypertension
AU2006235200A1 (en) * 2005-04-15 2006-10-19 Regenertech Pty Limited Use of Neuropeptide Y (NPY) and agonists and antagonists thereof for tissue regeneration
US8118779B2 (en) * 2006-06-30 2012-02-21 Warsaw Orthopedic, Inc. Collagen delivery device
US9593150B2 (en) * 2012-07-16 2017-03-14 The Scripps Research Institute Immunoglobulin-binding human mycoplasma antigens and methods of use thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US69246A (en) * 1867-09-24 qfackenbush
US144290A (en) * 1873-11-04 Improvement in churn-dashers
US72847A (en) * 1867-12-31 Eliphaiibt hall
DE69229283T2 (en) * 1991-11-06 1999-09-23 Garvan Inst Med Res HUMAN NEUROPEPTIDE Y-Y1 RECEPTOR
JPH10508486A (en) * 1994-11-07 1998-08-25 メルク エンド カンパニー インコーポレーテッド Modified neuropeptide Y receptor
US5602024A (en) * 1994-12-02 1997-02-11 Synaptic Pharmaceutical Corporation DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof
US5965392A (en) * 1996-04-08 1999-10-12 Bayer Corporation Neuropeptide Y receptor Y5 and nucleic acid sequences
US5985616A (en) * 1998-01-07 1999-11-16 Schering Corporation Chimeric mammalian NPY Y5 receptors
US6399631B1 (en) * 1999-07-23 2002-06-04 Pfizer Inc. Carbazole neuropeptide Y5 antagonists
CZ20021067A3 (en) * 1999-09-30 2002-11-13 Neurogen Corporation Certain alkylenediamine substituted pyrazolo[1,5-a]- 1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
WO2001023389A2 (en) * 1999-09-30 2001-04-05 Neurogen Corporation Certain alkylene diamine-substituted heterocycles
WO2001055103A2 (en) * 2000-01-28 2001-08-02 Neurogen Corporation Chimeric neuropeptide y receptors
ES2249384T3 (en) * 2000-12-12 2006-04-01 Neurogen Corporation ESPIRO (ISOBENZOFURAN-1,4'-PIPERADIN) -3-ONAS AND 3H-ESPIROBENZOFURAN-1,4-PIPERIDINAS.
CA2403307A1 (en) * 2001-10-23 2003-04-23 Neurogen Corporation Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives

Also Published As

Publication number Publication date
US20050221428A1 (en) 2005-10-06
JP2004500820A (en) 2004-01-15
EP1263768A2 (en) 2002-12-11
US20050019869A1 (en) 2005-01-27
CA2394332A1 (en) 2001-08-02
WO2001055103A2 (en) 2001-08-02
US20010031474A1 (en) 2001-10-18
EP1263768A4 (en) 2004-05-12
WO2001055103A3 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
AU2001255798A1 (en) Glucagon antagonists
AU2002225730A1 (en) Compounds
AUPQ661800A0 (en) Insulin-potentiating compounds
AU2001265871A1 (en) Substituted sulfonylaminopyrimidines
AU2001254731A1 (en) Substituted phenyluracils
AU2001239731A1 (en) Chimeric neuropeptide y receptors
AU2001258255A1 (en) Substituted benzoylcyclohexenones
AU2001240097A1 (en) G protein-coupled receptors
AU2002225724A1 (en) Motilide compounds
AU2002239291A1 (en) G protein coupled receptors
AU2002217285A1 (en) Compounds
AU2001233961A1 (en) Bore cleaning
AU2001249922A1 (en) G protein-coupled receptors
AU2001260643A1 (en) Ectocornea extension promoters
AU2001259322A1 (en) G protein-coupled receptors
AU2002223604A1 (en) Substituted phenyluracils
AU2001257231A1 (en) Novel g protein-coupled receptors
AU2000266120A1 (en) Chimeric receptors and their uses
AU2002216043A1 (en) Compounds
AU2001253594A1 (en) Novel g protein-coupled receptors
AU2002217000A1 (en) Spray can
AU7634201A (en) 6-methyl-4-trihalomethyltriazine compounds
AU2001263346A1 (en) G protein-coupled receptors
AU2001288254A1 (en) Novel g protein-coupled receptors
AU2001241735A1 (en) Novel g protein-coupled receptors